Login / Signup

The Rare Diseases Clinical Research Network: a model for clinical trial readiness.

Joanne M LumsdenTiina K Urv
Published in: Therapeutic advances in rare disease (2023)
The RDCRN program has successfully addressed some significant challenges while developing treatments for rare diseases. However, looking to the future and being agile in facing new challenges that arise as science progresses is important.
Keyphrases
  • clinical trial
  • public health
  • quality improvement
  • open label
  • phase ii
  • randomized controlled trial
  • double blind
  • network analysis